IE52071B1 - Novel tri-substituted imidazole derivatives processes for their manufacture,pharmaceutical preparations containing them,and their use - Google Patents

Novel tri-substituted imidazole derivatives processes for their manufacture,pharmaceutical preparations containing them,and their use

Info

Publication number
IE52071B1
IE52071B1 IE1680/81A IE168081A IE52071B1 IE 52071 B1 IE52071 B1 IE 52071B1 IE 1680/81 A IE1680/81 A IE 1680/81A IE 168081 A IE168081 A IE 168081A IE 52071 B1 IE52071 B1 IE 52071B1
Authority
IE
Ireland
Prior art keywords
phenyl
substituted
formula
carbon atoms
lower alkoxy
Prior art date
Application number
IE1680/81A
Other languages
English (en)
Other versions
IE811680L (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE811680L publication Critical patent/IE811680L/xx
Publication of IE52071B1 publication Critical patent/IE52071B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
IE1680/81A 1980-07-25 1981-07-24 Novel tri-substituted imidazole derivatives processes for their manufacture,pharmaceutical preparations containing them,and their use IE52071B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH571580 1980-07-25

Publications (2)

Publication Number Publication Date
IE811680L IE811680L (en) 1982-01-25
IE52071B1 true IE52071B1 (en) 1987-06-10

Family

ID=4298165

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1680/81A IE52071B1 (en) 1980-07-25 1981-07-24 Novel tri-substituted imidazole derivatives processes for their manufacture,pharmaceutical preparations containing them,and their use

Country Status (23)

Country Link
US (1) US4447431A (OSRAM)
EP (1) EP0045081B1 (OSRAM)
JP (1) JPS5756466A (OSRAM)
KR (13) KR850000883B1 (OSRAM)
AR (1) AR230269A1 (OSRAM)
AT (1) ATE17349T1 (OSRAM)
AU (2) AU7340481A (OSRAM)
CA (1) CA1175431A (OSRAM)
DD (2) DD201677A5 (OSRAM)
DE (1) DE3173434D1 (OSRAM)
DK (1) DK331881A (OSRAM)
ES (8) ES8301472A1 (OSRAM)
FI (1) FI812326A7 (OSRAM)
GB (1) GB2080805B (OSRAM)
GR (1) GR75287B (OSRAM)
IE (1) IE52071B1 (OSRAM)
IL (1) IL63410A (OSRAM)
NO (1) NO812542L (OSRAM)
NZ (1) NZ197828A (OSRAM)
PL (8) PL237002A1 (OSRAM)
PT (1) PT73424B (OSRAM)
SU (8) SU1235454A3 (OSRAM)
ZA (1) ZA815078B (OSRAM)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123831B (en) * 1981-07-20 1986-01-15 Ciba Geigy Ag Trisubstituted oxazo compounds
EP0084756A1 (de) * 1982-01-22 1983-08-03 Ciba-Geigy Ag Trisubstituierte Oxazaverbindungen
FR2633291B1 (fr) * 1988-06-27 1990-09-07 Oreal Derives d'hydroxy-4 isoxazoles, leur procede de preparation et compositions cosmetiques et pharmaceutiques les contenant
US5252322A (en) * 1989-09-22 1993-10-12 The Gillette Company Skin tanning compositions containing imidazoles
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
US5916891A (en) * 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
IL104369A0 (en) * 1992-01-13 1993-05-13 Smithkline Beecham Corp Novel compounds and compositions
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5670527A (en) * 1993-07-16 1997-09-23 Smithkline Beecham Corporation Pyridyl imidazole compounds and compositions
EP1306377A3 (en) * 1993-11-08 2003-05-07 Smithkline Beecham Corporation Pyridyl-oxazoles and their use as cytokines inhibitors
US5723477A (en) * 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US5739143A (en) * 1995-06-07 1998-04-14 Smithkline Beecham Corporation Imidazole compounds and compositions
US6369068B1 (en) 1995-06-07 2002-04-09 Smithkline Beecham Corporation Amino substituted pyrimidine containing compounds
IL118544A (en) 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
ZA9610687B (en) * 1995-12-22 1997-09-29 Smithkline Beecham Corp Novel synthesis.
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
AP9700912A0 (en) 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
ZA97175B (en) * 1996-01-11 1997-11-04 Smithkline Beecham Corp Novel substituted imidazole compounds.
ATE247470T1 (de) * 1996-01-11 2003-09-15 Smithkline Beecham Corp Neue substituierte imidazolverbindungen
JP2000507558A (ja) * 1996-03-25 2000-06-20 スミスクライン・ビーチャム・コーポレイション Ｃｎｓ損傷についての新規な治療
EP0956018A4 (en) 1996-08-21 2000-01-12 Smithkline Beecham Corp IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE
US5929076A (en) * 1997-01-10 1999-07-27 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
IL132318A0 (en) * 1997-04-24 2001-03-19 Ortho Mcneil Pharm Inc Substituted imidazoles useful in the treatment of inflammatory diseases
US20020156104A1 (en) 1997-06-13 2002-10-24 Jerry L. Adams Novel pyrazole and pyrazoline substituted compounds
EP0994870A4 (en) 1997-06-19 2002-10-23 Smithkline Beecham NEW IMIDAZOLE COMPOUNDS SUBSTITUTED BY AN ARYLOXYREST
TW517055B (en) 1997-07-02 2003-01-11 Smithkline Beecham Corp Novel substituted imidazole compounds
US6562832B1 (en) 1997-07-02 2003-05-13 Smithkline Beecham Corporation Substituted imidazole compounds
US6251914B1 (en) 1997-07-02 2001-06-26 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
US7301021B2 (en) * 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
US6489325B1 (en) 1998-07-01 2002-12-03 Smithkline Beecham Corporation Substituted imidazole compounds
AR016294A1 (es) * 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
WO1999017776A1 (en) 1997-10-08 1999-04-15 Smithkline Beecham Corporation Novel cycloalkenyl substituted compounds
US6335340B1 (en) 1997-12-19 2002-01-01 Smithkline Beecham Corporation compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses
WO1999061437A1 (en) 1998-05-22 1999-12-02 Smithkline Beecham Corporation Novel 2-alkyl substituted imidazole compounds
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
US6599910B1 (en) * 1998-08-20 2003-07-29 Smithkline Beecham Corporation Substituted triazole compounds
ATE258055T1 (de) 1998-11-04 2004-02-15 Smithkline Beecham Corp Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
US6239279B1 (en) 1998-12-16 2001-05-29 Smithkline Beecham Corporation Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
KR20020050294A (ko) 1999-11-22 2002-06-26 피터 기딩스 신규화합물
US6759410B1 (en) * 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
JP2003514900A (ja) 1999-11-23 2003-04-22 スミスクライン・ビーチャム・コーポレイション ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４−ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
ATE305787T1 (de) 1999-11-23 2005-10-15 Smithkline Beecham Corp 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
ATE281439T1 (de) 1999-11-23 2004-11-15 Smithkline Beecham Corp 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
US7235551B2 (en) * 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
DE60103136T2 (de) * 2000-03-06 2004-10-28 Smithkline Beecham Plc, Brentford Imidazolderivate als Raf-Kinase Inhibitoren
GB0005357D0 (en) 2000-03-06 2000-04-26 Smithkline Beecham Plc Compounds
CA2426654C (en) * 2000-10-23 2010-12-21 Smithkline Beecham Corporation 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
GB0112348D0 (en) * 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
JP2005504793A (ja) * 2001-09-05 2005-02-17 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー Ｒａｆキナーゼ阻害剤としてのヘテロサイクルカルボキサミド誘導体
RU2312101C2 (ru) * 2001-12-18 2007-12-10 Ф.Хоффманн-Ля Рош Аг Цис-имидазолины в качестве ингибиторов mdm2
TW200505446A (en) * 2003-01-17 2005-02-16 Fuj Isawa Pharmaceutical Co Ltd Inhibitor of cox
US20070043084A1 (en) * 2003-05-08 2007-02-22 Astellas Pharma Inc. 1,2-Diarylimidazoles useful as inhibitors of cox
MY145343A (en) 2005-03-25 2012-01-31 Glaxo Group Ltd Novel compounds
KR20080002865A (ko) * 2005-03-25 2008-01-04 글락소 그룹 리미티드 피리도[２,３-ｄ]피리미딘-７-온 및３,４-디히드로피리미도[４,５-ｄ]피리미딘-２(１ｈ)-온유도체의 제조 방법
WO2013049272A2 (en) 2011-09-29 2013-04-04 Theraceutix, Llc Composition and method for treatment of symptoms associated with various skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558645A (en) * 1968-07-08 1971-01-26 Sandoz Ag 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids
CH561716A5 (OSRAM) * 1971-05-10 1975-05-15 Ciba Geigy Ag
GB1469532A (en) * 1973-06-28 1977-04-06 Dumex Ltd As Imimdazolyl-alkanoic acid derivatives
US4372964A (en) * 1980-10-30 1983-02-08 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols

Also Published As

Publication number Publication date
KR850002749A (ko) 1985-05-15
ES8306119A1 (es) 1983-05-16
ES514579A0 (es) 1983-05-16
ZA815078B (en) 1982-07-28
CA1175431A (en) 1984-10-02
ATE17349T1 (de) 1986-01-15
PL232352A1 (OSRAM) 1982-12-20
SU1235454A3 (ru) 1986-05-30
JPS5756466A (en) 1982-04-05
GB2080805B (en) 1984-03-07
US4447431A (en) 1984-05-08
KR850002748A (ko) 1985-05-15
SU1205763A3 (ru) 1986-01-15
KR850002746A (ko) 1985-05-15
NZ197828A (en) 1985-11-08
KR850002754A (ko) 1985-05-15
ES8306122A1 (es) 1983-05-16
KR850002756A (ko) 1985-05-15
KR850000892B1 (ko) 1985-06-26
ES514585A0 (es) 1983-07-01
DE3173434D1 (en) 1986-02-20
SU1227112A3 (ru) 1986-04-23
ES8306124A1 (es) 1983-05-16
KR850000884B1 (ko) 1985-06-26
ES514584A0 (es) 1983-05-16
KR850002745A (ko) 1985-05-15
SU1145928A3 (ru) 1985-03-15
DD202554A5 (de) 1983-09-21
KR850002755A (ko) 1985-05-15
PL237005A1 (en) 1983-02-28
PT73424A (en) 1981-08-01
ES504257A0 (es) 1982-12-01
ES8306121A1 (es) 1983-05-16
SU1152520A3 (en) 1985-04-23
KR850000888B1 (ko) 1985-06-26
KR850000886B1 (ko) 1985-06-26
PL237000A1 (en) 1983-02-28
PL237001A1 (en) 1983-02-28
FI812326L (fi) 1982-01-26
EP0045081A3 (en) 1982-04-07
EP0045081A2 (de) 1982-02-03
PL237004A1 (en) 1983-02-28
KR850000887B1 (ko) 1985-06-26
IL63410A0 (en) 1981-10-30
KR850000889B1 (ko) 1985-06-26
ES8306120A1 (es) 1983-05-16
FI812326A7 (fi) 1982-01-26
ES514580A0 (es) 1983-05-16
ES8307245A1 (es) 1983-07-01
AU7340481A (en) 1982-01-28
KR850002747A (ko) 1985-05-15
DK331881A (da) 1982-01-26
KR850000891B1 (ko) 1985-06-26
GB2080805A (en) 1982-02-10
KR850002750A (ko) 1985-05-15
ES514583A0 (es) 1983-05-16
KR850000911B1 (ko) 1985-06-27
ES514581A0 (es) 1983-05-16
KR850001064B1 (ko) 1985-07-25
EP0045081B1 (de) 1986-01-08
PT73424B (en) 1983-06-20
KR850000885B1 (ko) 1985-06-26
SU1205764A3 (ru) 1986-01-15
IE811680L (en) 1982-01-25
KR850002753A (ko) 1985-05-15
PL135822B1 (en) 1985-12-31
ES8301472A1 (es) 1982-12-01
KR850002752A (ko) 1985-05-15
SU1169534A3 (ru) 1985-07-23
GR75287B (OSRAM) 1984-07-13
ES514582A0 (es) 1983-05-16
PL237003A1 (en) 1983-02-28
ES8306123A1 (es) 1983-05-16
KR830006230A (ko) 1983-09-20
SU1138023A3 (ru) 1985-01-30
KR850002744A (ko) 1985-05-15
AR230269A1 (es) 1984-03-01
NO812542L (no) 1982-01-26
KR850000873B1 (ko) 1985-06-22
PL237002A1 (en) 1983-02-28
PL236997A1 (en) 1983-01-03
KR850000890B1 (ko) 1985-06-26
AU5655586A (en) 1986-09-11
IL63410A (en) 1986-04-29
DD201677A5 (de) 1983-08-03
KR850000883B1 (ko) 1985-06-26

Similar Documents

Publication Publication Date Title
US4447431A (en) Tri-substituted imidazole derivatives, pharmaceutical preparations containing them, and their use
NZ238407A (en) 5-hydroxy-2-(substituted methyl)amino pyridine derivatives and pharmaceuticals compositions
FR2698873A1 (fr) Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
EP0034798A2 (en) Antiinflammatory 4,5-diaryl-2-(substituted-thio)pyrroles and their corresponding sulfoxides and sulfones
HU214627B (hu) Eljárás 2,4- és 2,5-szubsztituált piridin-N-oxid-származékok, és hatóanyagként ezeket tartalmazó gyógyászati készítmények előállítására
WO1983002611A1 (fr) Composes diazoiques a triple substitution
US4622421A (en) Phenylalkanoic acid derivatives and their use
US4766133A (en) (Bezimidazol-2-yl)-pyridinium compounds
US4694018A (en) Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
US4590205A (en) Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
US5137904A (en) Thiohydantoin inhibitors of collagen-induced and ADP-induced platelet aggregation
US3833594A (en) Amino derivatives of pyrazolopyridine carboxylic acids and esters
US4308277A (en) 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same
EP0046451A2 (de) Neue Diaryl-Imidazol-Verbindungen, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung
US3971797A (en) S,S'-bis(pyridylmethyl)-carbonodithioates
EP0162217A1 (de) 1,2,4-Triazacycloalkadienderivate
JPH0625151B2 (ja) ２−置換シクロヘプトイミダゾ−ル誘導体、抗潰瘍剤及びその製造方法
JPH0753730B2 (ja) イミダゾピラゾール誘導体
US4595689A (en) 4-(8-bromodibenz[b,f]oxepin-10-yl)-1,2,3,6-tetrahydro-1-methylpyridine and 4-(2-bromodibenzo[a,d]cyclophetatriene-11-yl)-1,2,3,6-tetrahydro-1-methylpyridine for dermal inflammation
US3471619A (en) Rodenticidal compositions containing certain 5 - (r-r1-r2 - methyl) - 7-(r3-r4-methylene) - (r6) - 5 - norbornene-2,3- dicarboximides
EP0035474B1 (de) Neue Amidine, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung
NZ198215A (en) Immunoregulatory compositions containing pyridine derivatives
EP0157259A1 (de) 3-Mercapto-1,2,4-triazacycloalkadienderivate
NZ207254A (en) Heterocyclyl-substituted oxazoles and pharmaceuticals
NO833349L (no) Trisubstituerte diazaderivater